Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma
Vinarov, A.Z.; Aliaev, I.G.; Lokshin, K.L.
Urologiia 1: 84; 86-87
2009
ISSN/ISBN: 1728-2985 PMID: 19432240 Document Number: 14804
Document emailed within 1 workday
Related Documents
Aliaev, I.G.; Vinarov, A.Z.; Demidko, I.L.; Spivak, L.G. 2013: The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia Urologiia 4: 32-36Ibishev, K.S.; Krainy, P.A.; Mitusov, V.V.; Sizyakin, D.V.; Magomedov, G.A. 2019: A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue Urologiia 1: 40-46
Glemain, P.; Coulange, C.; Billebaud, T.; Gattegno, B.; Muszynski, R.ël.; Loeb, G.ér. 2002: Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 12(3): 395-403; Discussion 404
Tarayre, J.P.; Delhon, A.; Lauressergues, H.; Stenger, A.; Barbara, M.; Bru, M.; Villanova, G.; Caillol, V.; Aliaga, M. 1983: Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr Annales Pharmaceutiques Francaises 41(6): 559-570
Casarosa, C.; Cosci di Coscio, M.; Fratta, M. 1988: Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone Clinical Therapeutics 10(5): 585-588
Vinarov, A.Z.; Aliaev, I.G.; Apolikhin, O.I.; Mazo, E.B.; Darenkov, S.P.; Demidko, I.L.; Lokshin, K.L.; Medvedev, A.A.; Permiakova, O.V.; Spivak, L.G.; Shkol'nikov, M.E. 2010: Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression Urologiia 6: 3-10
Adriazola Semino, M.; Lozano Ortega, J.L.; García Cobo, E.; Tejeda Báñez, E.; Romero Rodríguez, F. 1992: Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens Archivos Espanoles de Urologia 45(3): 211-213
Pushkar', D.Iu.; Loran, O.B.; Petrov, S.B.; Kogan, M.I.; Zhuravlev, V.N. 2008: Efficacy and safety of revocarin in patients with impaired micturition due to prostatic adenoma. An open non-comparative study: results of a multicenter trial Urologiia 2008(1): 23 25-6
Dufour, B.; Choquenet, C.; Revol, M.; Faure, G.; Jorest, R. 1984: Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma Annales d'Urologie 18(3): 193-195
Thieblot, L.; Berthelay, S.; Berthelay, J. 1971: Preventive and curative action of a bark extract from an African plant, Pygeum africanum, on experimental prostatic adenoma in rats Therapie 26(3): 575-580
Miller, A.M.; Iaroshenko, V.P.; Soroka, P.V.; Stakhnev, E.I. 2008: Efficacy of vitaprost forte in patients with prostatic adenoma Urologiia 5: 50; 52-54
Shafranov, D.V.; Mariupol'skiĭ, A.A. 2011: Vitaprost-forte in the treatment of patients with prostatic adenoma Urologiia 6: 54; 56-59
Glybochko, P.V.; Anafin, T.G.; Shalekenov, S.B. 2011: Combined endoscopic treatment of patients with prostatic adenoma Urologiia 6: 81-83
Danilov, V.V.; Vasil'chenko, A.V.; Danilova, T.I.; Besedin, S.A.; Borshchenko, S.A.; Danilov, V.V. 2010: Pharmacourodynamic non-invasive studies in patients with prostatic adenoma Urologiia 6: 16-19
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Buĭlov, V.M. 1984: X-ray television study in the excretory urography of patients with prostatic adenoma Vestnik Rentgenologii i Radiologii 1984(1): 79-82
Steinmetz, L.; Adamkiewicz, K. 1974: Urine flowmetry in patients with prostatic adenoma treated with Raveron Polski Przeglad Chirurgiczny 46(10a): 1375-1382
Maksimov, V.A.; Khodyreva, L.A.; Dudareva, A.A.; Al'bitskaia, A.I. 2011: Combined treatment of patients with prostatic adenoma and overactive bladder Urologiia 6: 46; 48-50
Tachev, S.; Petrov, P.; Simeonov, P. 1988: Therapeutic potentials of the preparation dibenziran in patients with prostatic adenoma Khirurgiia 41(4): 30-32
Aliaev, I.G.; Gadzhieva, Z.K.; Petrovskiĭ, N.V. 2010: Overactive bladder in patients with infravesical obstruction caused by prostatic adenoma Urologiia 6: 10-15